KEY vs NRIX · P/E 13, rev $7.51B vs rev $54.5M
KeyCorp (KEY) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the KEY and NRIX stock pages for the full models.
Not investment advice.